David van Duin, MD, PhD

Associate Professor of Medicine
University of North Carolina

David van Duin, MD, PhD, FIDSA, FAST. Associate Professor in the Infectious Diseases Division at the University of North Carolina. Dr. van Duin is the founding Director of the Immunocompromised Host ID service. His main research interests are infections caused by multi-drug resistant Gram-negative bacteria, especially carbapenem-resistant Enterobacteriaceae, and infections in immunocompromised patients.

Disclosure: Achaogen (Individual(s) Involved: Self): Advisor or Review Panel member; Allergan (Individual(s) Involved: Self): Advisor or Review Panel member; Astellas (Individual(s) Involved: Self): Advisor or Review Panel member; MedImmune (Individual(s) Involved: Self): Advisor or Review Panel member; Merck (Individual(s) Involved: Self): Advisor or Review Panel member; NeuMedicine (Individual(s) Involved: Self): Advisor or Review Panel member; Qpex (Individual(s) Involved: Self): Advisor or Review Panel member; Roche (Individual(s) Involved: Self): Advisor or Review Panel member; Sanofi-Pasteur (Individual(s) Involved: Self): Advisor or Review Panel member; Shionogi (Individual(s) Involved: Self): Advisor or Review Panel member; T2 Biosystems (Individual(s) Involved: Self): Advisor or Review Panel member; Tetraphase (Individual(s) Involved: Self): Advisor or Review Panel member

Presentation(s):

• 158 - Intra- and Inter-hospital Epidemiology of Carbapenem-resistant klebsiella Pneumoniae in US Hospitals

  Oral Abstract

• 24 - Epidemiologically Important Multi-drug Resistant Organisms in Transplantation

  Thursday, October 22, 2020
  12:30pm – 1:45pm EDT